These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20510813)

  • 21. MammoSite and accelerated partial breast irradiation: Rethinking one-size-fits-all breast irradiation after lumpectomy.
    White J
    Brachytherapy; 2005; 4(3):183-5. PubMed ID: 16182217
    [No Abstract]   [Full Text] [Related]  

  • 22. The biological significance of locoregional recurrence following breast conserving therapy.
    Reid IM; Donohue JH
    Semin Surg Oncol; 1992; 8(3):113-6. PubMed ID: 1496219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local recurrence of breast cancer after cytological evaluation of lumpectomy margins.
    Cox CE; Pendas S; Ku NN; Reintgen DS; Greenberg HS; Nicosia SV
    Am Surg; 1998 Jun; 64(6):533-7; discussion 537-8. PubMed ID: 9619174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing indications for surgery in patients with stage IV breast cancer: a current perspective.
    Morrogh M; Park A; Norton L; King TA
    Cancer; 2008 Apr; 112(7):1445-54. PubMed ID: 18306353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immediate latissimus dorsi miniflap volume replacement for partial mastectomy: use of intra-operative frozen sections to confirm negative margins.
    Rusby JE; Paramanathan N; Laws SA; Rainsbury RM
    Am J Surg; 2008 Oct; 196(4):512-8. PubMed ID: 18809053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Access to multidisciplinary cancer care: is it linked to the use of breast-conserving surgery with radiation for early-stage breast carcinoma?
    Baldwin LM; Taplin SH; Friedman H; Moe R
    Cancer; 2004 Feb; 100(4):701-9. PubMed ID: 14770424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early results from a novel quality outcomes program: the American Society Of Breast Surgeons' Mastery of Breast Surgery.
    Clifford EJ; De Vol EB; Pockaj BA; Wilke LG; Boughey JC
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():233-41. PubMed ID: 20853039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and trends of surgical modalities for breast cancer in China: a review of 16-year data.
    Yu KD; Di GH; Wu J; Lu JS; Shen KW; Shen ZZ; Shao ZM
    Ann Surg Oncol; 2007 Sep; 14(9):2502-9. PubMed ID: 17564750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast-conserving treatment of breast cancer--oncological and reconstructive aspects.
    Kramer S; Darsow M; Kummel S; Kimmig R; Rezai M
    Gynakol Geburtshilfliche Rundsch; 2008; 48(2):56-62. PubMed ID: 18431044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Local recurrence of breast cancer].
    Santoro G; Nacchia F; Rocco P
    G Chir; 1999; 20(8-9):378-80. PubMed ID: 10444929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathologic features related to local recurrence following lumpectomy and irradiation.
    Lagios MD
    Semin Surg Oncol; 1992; 8(3):122-8. PubMed ID: 1496221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer treatment beliefs and influences among surgeons in areas of scientific uncertainty.
    Schroen AT; Brenin DR
    Am J Surg; 2010 Apr; 199(4):491-9. PubMed ID: 20359569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outpatient mastectomy: clinical, payer, and geographic influences.
    Case C; Johantgen M; Steiner C
    Health Serv Res; 2001 Oct; 36(5):869-84. PubMed ID: 11666108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical margins in lumpectomy for breast cancer.
    Jatoi I
    N Engl J Med; 2012 Sep; 367(13):1269-70; author reply 1270. PubMed ID: 23013096
    [No Abstract]   [Full Text] [Related]  

  • 35. An improved process for breast cancer margin identification and orientation.
    Beland M
    AORN J; 2009 Oct; 90(4):525-9. PubMed ID: 19801004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality measures for breast cancer surgery: initial validation of feasibility and assessment of variation among surgeons.
    McCahill LE; Privette A; James T; Sheehey-Jones J; Ratliff J; Majercik D; Krag DN; Stanley M; Harlow S
    Arch Surg; 2009 May; 144(5):455-62; discussion 462-3. PubMed ID: 19451489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma.
    Lazovich D; Solomon CC; Thomas DB; Moe RE; White E
    Cancer; 1999 Aug; 86(4):628-37. PubMed ID: 10440690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of surgical margin control in breast-conserving therapy.
    Ziogas D; Xeropotamos N; Batsis C
    Ann Surg Oncol; 2008 Feb; 15(2):659-60. PubMed ID: 17932719
    [No Abstract]   [Full Text] [Related]  

  • 39. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.
    Evans RA
    Cancer; 2003 Dec; 98(11):2522-3; author reply 2523-4. PubMed ID: 14635089
    [No Abstract]   [Full Text] [Related]  

  • 40. The preferred treatment for young women with breast cancer--mastectomy versus breast conservation.
    van Nes JG; van de Velde CJ
    Breast; 2006 Dec; 15 Suppl 2():S3-10. PubMed ID: 17382859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.